MX2009013186A - Derivados de piperazina y [1,4]diazepan como antagonistas de neurocinina. - Google Patents
Derivados de piperazina y [1,4]diazepan como antagonistas de neurocinina.Info
- Publication number
- MX2009013186A MX2009013186A MX2009013186A MX2009013186A MX2009013186A MX 2009013186 A MX2009013186 A MX 2009013186A MX 2009013186 A MX2009013186 A MX 2009013186A MX 2009013186 A MX2009013186 A MX 2009013186A MX 2009013186 A MX2009013186 A MX 2009013186A
- Authority
- MX
- Mexico
- Prior art keywords
- sup
- lower alkyl
- hydrogen
- halogen
- substituted
- Prior art date
Links
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 title 2
- FQUYSHZXSKYCSY-UHFFFAOYSA-N 1,4-diazepane Chemical class C1CNCCNC1 FQUYSHZXSKYCSY-UHFFFAOYSA-N 0.000 title 1
- 239000005557 antagonist Substances 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 9
- 229910052739 hydrogen Inorganic materials 0.000 abstract 5
- 239000001257 hydrogen Substances 0.000 abstract 5
- 229910052736 halogen Inorganic materials 0.000 abstract 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 3
- 125000003545 alkoxy group Chemical group 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- 125000001153 fluoro group Chemical group F* 0.000 abstract 2
- 125000005843 halogen group Chemical group 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- 125000001072 heteroaryl group Chemical group 0.000 abstract 2
- 150000002431 hydrogen Chemical class 0.000 abstract 2
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 abstract 1
- 208000020401 Depressive disease Diseases 0.000 abstract 1
- 102000002003 Neurokinin-3 Receptors Human genes 0.000 abstract 1
- 108010040716 Neurokinin-3 Receptors Proteins 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 abstract 1
- 208000018737 Parkinson disease Diseases 0.000 abstract 1
- 208000028017 Psychotic disease Diseases 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 230000036506 anxiety Effects 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- CBOIHMRHGLHBPB-UHFFFAOYSA-N hydroxymethyl Chemical compound O[CH2] CBOIHMRHGLHBPB-UHFFFAOYSA-N 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000002464 receptor antagonist Substances 0.000 abstract 1
- 229940044551 receptor antagonist Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 201000000980 schizophrenia Diseases 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
- C07D295/26—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
La presente invención se refiere a un compuesto de la fórmula (I) (ver fórmula (I)) en donde R1 es hidrógeno o alquilo inferior; R2 es hidrógeno, fluoro, hidroxi o alquilo inferior; R3 es hidrógeno o alquilo inferior; R4 es -CHR5-A; R5 es hidrógeno, alquilo inferior, fluoro, CF3, CH2OH o cicloalquilo; A es arilo o heteroarilo, cuyos anillos son no sustituidos o sustituidos por (R6)O R6 puede ser igual o no cuando o sea más de uno, y es heteroarilo, alquilo inferior, alcoxi inferior, ciano, halógeno, alquilo inferior sustituido por halógeno, alcoxi inferior sustituido por halógeno o NR7R8 o es 1, 2 ó 3; R7, R8 son independientemente hidrógeno o alquilo inferior; R9 es alquilo inferior; R10 es alquilo inferior, alcoxi inferior o halógeno; n es 1 ó 2; m es 1 ó 2; o a una sal de adición con ácidos farmacéuticamente aceptables del mismo. La invención incluye todas las formas estereoisoméricas, incluyendo diastereoisómeros y enantiómeros individuales del compuesto de la fórmula (I) así como mezclas racémicas y no racémicas del mismo. Se ha encontrado que los presentes compuestos son antagonistas del receptor de NK-3 de alto potencial para el tratamiento de depresión, dolor, psicosis, mal de Parkinson, esquizofrenia, ansiedad y trastorno de hiperactividad por déficit de atención (ADHD).
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07110143 | 2007-06-13 | ||
| PCT/EP2008/056878 WO2008151969A1 (en) | 2007-06-13 | 2008-06-04 | Piperazine and [1,4] diazepan derivatives as nk antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2009013186A true MX2009013186A (es) | 2010-01-15 |
Family
ID=39540616
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2009013186A MX2009013186A (es) | 2007-06-13 | 2008-06-04 | Derivados de piperazina y [1,4]diazepan como antagonistas de neurocinina. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7592345B2 (es) |
| EP (1) | EP2167509A1 (es) |
| JP (1) | JP2010529158A (es) |
| KR (1) | KR101177977B1 (es) |
| CN (1) | CN101679457B (es) |
| AU (1) | AU2008263982B2 (es) |
| BR (1) | BRPI0814253A2 (es) |
| CA (1) | CA2690299A1 (es) |
| IL (1) | IL202278A0 (es) |
| MX (1) | MX2009013186A (es) |
| WO (1) | WO2008151969A1 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2015245901B2 (en) * | 2014-04-10 | 2017-05-25 | Dalhousie University | Treatment of Parkinson's disease through ArfGAP1 inhibition using substituted piperazine derivatives |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5434158A (en) * | 1994-04-26 | 1995-07-18 | Merck & Co., Inc. | Spiro-substituted azacycles as neurokinin-3 antagonists |
| GB0027701D0 (en) | 2000-11-13 | 2000-12-27 | Smithkline Beecham Spa | Novel compounds |
| GB0130261D0 (en) * | 2001-12-18 | 2002-02-06 | Pfizer Ltd | Lactams as tachykinin antagonists |
-
2008
- 2008-06-03 US US12/132,002 patent/US7592345B2/en not_active Expired - Fee Related
- 2008-06-04 BR BRPI0814253-0A2A patent/BRPI0814253A2/pt not_active IP Right Cessation
- 2008-06-04 KR KR1020107000625A patent/KR101177977B1/ko not_active Expired - Fee Related
- 2008-06-04 MX MX2009013186A patent/MX2009013186A/es active IP Right Grant
- 2008-06-04 EP EP08760461A patent/EP2167509A1/en not_active Withdrawn
- 2008-06-04 WO PCT/EP2008/056878 patent/WO2008151969A1/en not_active Ceased
- 2008-06-04 CA CA2690299A patent/CA2690299A1/en not_active Abandoned
- 2008-06-04 CN CN2008800197239A patent/CN101679457B/zh not_active Expired - Fee Related
- 2008-06-04 AU AU2008263982A patent/AU2008263982B2/en not_active Ceased
- 2008-06-04 JP JP2010511582A patent/JP2010529158A/ja active Pending
-
2009
- 2009-11-23 IL IL202278A patent/IL202278A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2010529158A (ja) | 2010-08-26 |
| AU2008263982A1 (en) | 2008-12-18 |
| IL202278A0 (en) | 2010-06-16 |
| CN101679457B (zh) | 2012-09-05 |
| CA2690299A1 (en) | 2008-12-18 |
| AU2008263982B2 (en) | 2012-09-27 |
| EP2167509A1 (en) | 2010-03-31 |
| KR101177977B1 (ko) | 2012-08-28 |
| US7592345B2 (en) | 2009-09-22 |
| WO2008151969A1 (en) | 2008-12-18 |
| KR20100023957A (ko) | 2010-03-04 |
| US20080312216A1 (en) | 2008-12-18 |
| BRPI0814253A2 (pt) | 2015-01-06 |
| CN101679457A (zh) | 2010-03-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2015015893A (es) | 2-fenilimidazo[1,2-a]pirimidinas como agentes formadores de imagen. | |
| MX2010001774A (es) | Pirrolidin aril-eteres como antagonistas de receptores de nk3. | |
| PH12012500690A1 (en) | Positive allosteric modulators (pam) | |
| MX366855B (es) | Compuestos perfluorados de 5,6-dihidro-4h-1,3-oxazin-2-amina como inhibidores de beta-secretasa y metodos de uso. | |
| PH12015502001A1 (en) | Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use | |
| HRP20140687T1 (hr) | Derivati benzofurana | |
| IL202236A0 (en) | Prolinamide derivatives as nk3 antagonists | |
| MX2010001080A (es) | Pirrolidin-aril-eteres como antagonistas de receptor de nk3. | |
| MY176030A (en) | Substituted benzamide derivatives | |
| AR070898A1 (es) | Derivados de arilsulfonil pirazolin carboxamidina como antagonistas de 5-ht6 | |
| AR070635A1 (es) | DERIVADOS DE PIRIDOPIRAZINONA QUE ESTIMULAN LA SECRECIoN DE INSULINA, MÉTODOS PARA OBTENERLOS, SU USO EN EL TRATAMIENTO DE LA DIABETES Y COMPOSICIONES FARMACEUTICAS. | |
| MX354815B (es) | Derivados heterociclicos como receptores asociados con las aminas traza (taars). | |
| MX2015014353A (es) | Derivados de 2-fenil- o 2-hetaril-imidazol[1,2-a]piridina. | |
| PH12016501100B1 (en) | Ethynyl-imidazolin-2,4-dione derivatives as mglur4 modulators | |
| MX2012001799A (es) | Derivados de pirrolidina como antagonistas del receptor de neuroquinona 3 (nk3). | |
| DE602006011725D1 (de) | 3-triazolylthioalkyl-3-azabicyclo ä3.1.0ühexane und ihre verwendung als liganden des dopamin-d3-rezeptors | |
| MX2011007272A (es) | Piperidinas de aroilamino y heteroaroilamino sustituidas como inhibidores de glyt-1. | |
| MX2012006293A (es) | Derivados de pirrolidina como antagonista del receptor nk-3. | |
| MX2009013186A (es) | Derivados de piperazina y [1,4]diazepan como antagonistas de neurocinina. | |
| NZ592478A (en) | Process for synthesis of amino-methyl tetraline derivatives | |
| MX340508B (es) | Derivados de pirrolidina como antagonistas del receptor de neuroquinina 3 (nk3). | |
| MX2009006972A (es) | Derivados de espiropiperidina como antagonistas de neuroquinina 3. | |
| Kumar et al. | Synthesis and evaluation of arylpiperazines derivatives of 3, 5-dioxo-(2H, 4H)-1, 2, 4-triazine as 5-HT1AR ligands | |
| MX2011008178A (es) | Derivados de pirrolidina como antagonistas del receptor de neuroquinina 3 (nk3). | |
| ATE367163T1 (de) | 4-(sulfanylpyrimidin-4-ylmethyl)morpholin- derivate und verwandte verbindungen als gaba- rezeptorliganden zur behandlung von angst, depression und epilepsie |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |